Mesenchymal stem cell therapy for cardiac repair.

Andrew J. Boyle, Ian K. McNiece, Joshua M. Hare

Research output: Contribution to journalArticlepeer-review


Stem cell therapy for repair of damaged cardiac tissue is an attractive option to improve the health of the growing number of heart failure patients. Mesenchymal stem cells (MSCs) possess unique properties that may make them a better option for cardiac repair than other cell types. Unlike other adult stem cells, they appear to escape allorecognition by the immune system and they have immune-modulating properties, thus making it possible to consider them for use as an allogeneic cell therapy product. There is a large and growing body of preclinical and early clinical experience with MSC therapy that shows great promise in realizing the potential of stem cell therapy to effect repair of damaged cardiac tissue. This review discusses the mechanism of action of MSC therapy and summarizes the current literature in the field.

Original languageEnglish (US)
Pages (from-to)65-84
Number of pages20
JournalMethods in molecular biology (Clifton, N.J.)
StatePublished - 2010
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Mesenchymal stem cell therapy for cardiac repair.'. Together they form a unique fingerprint.

Cite this